Nov 18, 2025

EP PerMed announced its 2026 call - "Personalized Medicine for CARdiovascular, MEtabolic, and kidNey diseases"

EP Per Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases

The EP PerMed has published its Call 2026 (JTC2026) "Personalized Medicine for CARdiovascular, MEtabolic, and kidNey diseases" (acronym: CARMEN2026), co-funded by the European Union. The aim is to promote multinational, innovative research projects in the School of Medicine (PM), with the aim of bringing together academic, clinical/public health sectors and private sector research teams.

The call has a two-stage structure and the available budget is approximately €38 million.

Aim of the call:
EP PerMed will fund human health research projects that develop innovative PM strategies for patients with cardiovascular, metabolic or renal diseases. Research projects can focus on a single disease or investigate combinations of these diseases. Applications should address one or more of the following aspects:

1. innovative personalized therapeutic approaches;
2. monitoring treatment response in order to customize treatment pathways
3. early prediction of disease risk and prevention of disease exacerbation or comorbidities.

The overarching goals of EP PerMed are:

To promote and enable interdisciplinary collaboration, i.e. multi-stakeholder research involving relevant disciplines such as preclinical and clinical research, bioinformatics/health informatics/data science, ELSA research, implementation research or health economics related to the proposed research topic, including analyses from an end-user perspective, to facilitate the implementation of personalized medicine;
Promote cross-sector collaboration, by involving the private sector (e.g. SMEs, small and medium-sized enterprises, industry) as well as regulatory/HTA (Health Technology Assessment) agencies and patient organizations.

Timetable and funding conditions:

Funding for universities via the BMG, BMFT decision still pending
December 16, 2025 - Info day
February 10, 2026 - Submission of project outlines
June 09, 2026 - Submission of full proposals
Collaborative projects with at least 3 partners from 3 participating countries

Participating countries:
Belgium (BE), Denmark (DK), Germany (DE), Estonia (EE), Finland (FI), France (FR), Greece (GR), Ireland (IE), Iceland (IS), Israel (IL), Italy*(IT), Latvia (LV), Lithuania (LT), Luxembourg (LU), Netherlands (NL), Norway (NO), Austria*(AT), Poland (PO), Portugal (PT), Romania (RO), Sweden (SE), Slovakia (SK), South Africa (ZA), Spain (ES), Czech Republic (CZ), Turkey (TR), Hungary (HU)

*Funding approval still pending

Further information:
https://www.eppermed.eu/funding-projects/calls/jtc2026/